Proteomics

Dataset Information

0

Proteomic profile of BxPC3 cells after RAD51 inhibition by treatment with BRC4


ABSTRACT: RAD51 protein is an evolutionarily conserved recombinase that plays a central role in homologous recombination (HR) and DNA double strand break (DSB) repair. RAD51 inactivation by small molecules has been proposed as a strategy to impair the BRCA2/RAD51 binding and, ultimately, the HR pathway, with the aim to make cancer cells more sensitive to PARP inhibitors (PARPi). This strategy, which mimics a synthetic lethality (SL) approach, has been successfully assayed in vitro by using myr-BRC4, a peptide derived from the fourth BRC repeat of BRCA2, being the strongest reported natural RAD51 binder. The present study applies a method to obtain a proteomic fingerprint for RAD51 inhibition by the myr-BRC4 peptide (designed for a more efficient cell entry) using a mass spectroscopy (MS) proteomic approach. We performed a comparative proteomic profiling of the myr-BRC4 treated vs. untreated BxPC-3 pancreatic cancer cells and evaluated the differential expression of proteins. Among the identified proteomic hits, we focused our attention on proteins shared by both the RAD51 and the BRCA2 interactomes, and on those whose reduction showed high statistical significance. Three downregulated proteins were identified (FANCI, FANCD2, and RPA3) and protein downregulation was confirmed through immunoblotting analysis, validating the MS approach. Our results suggest that, being a direct consequence of RAD51 inhibition, the detection of FANCD2, FANCI, and RPA3 downregulation could be used as an indicator for monitoring HR impairment.

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Carcinoma Cell, Epithelial Cell

DISEASE(S): Pancreatic Carcinoma

SUBMITTER: Kieran Wynne  

LAB HEAD: Giorgio Oliviero

PROVIDER: PXD042696 | Pride | 2023-08-15

REPOSITORIES: Pride

altmetric image

Publications


BRCA2 and RAD51 are two proteins that play a central role in homologous recombination (HR) and DNA double strand break (DSB) repair. BRCA2 assists RAD51 fibrillation and defibrillation through binding with its eight BRC repeats, with BRC4 being one of the most efficient and best characterized. RAD51 inactivation by small molecules has been proposed as a strategy to impair BRCA2/RAD51 binding and, ultimately, the HR pathway, with the aim of making cancer cells more sensitive to PARP inhibitors (P  ...[more]

Similar Datasets

2021-07-26 | MSV000087884 | MassIVE
2022-02-22 | PXD031168 | Pride
2023-03-11 | PXD028670 | Pride
2022-01-17 | GSE126546 | GEO
2020-03-09 | PXD017020 | Pride
2022-11-18 | PXD031632 | JPOST Repository
2022-06-07 | GSE148511 | GEO
2017-09-02 | GSE86394 | GEO
2022-02-18 | PXD029409 | Pride
2022-02-18 | PXD024280 | Pride